Pankaj Murarka, CEO and CIO of Renaissance Investment Managers, expects investors to look beyond weak near-term earnings and focus on a stronger recovery in the second half of the financial year and into next year. He argued that periods of…
Deven Choksey, MD of DRChoksey Finserv, believes easing crude oil prices and improving market sentiment could support a broader recovery across sectors. He remains positive on OMCs, private sector banks, pharma, and select consumer names, while also seeing value emerging…
HFCL reported its results for the March quarter earlier this month, where its revenue more than doubled in value from last year, rising 127.8%. Even on a sequential basis, revenue was up 51%.
The entity acquired by Park Medi World reported revenue of ₹55.74 crore in financial year 2026, ₹49.04 crore in financial year 2025 and ₹42.4 crore in financial year 2024.
As per the contract, Sterlite Technologies, via is subsidiary, will supply optical connectivity products as per customer specifications, for AI data center build-outs.
Of the 31 analysts who have coverage on Colgate-Palmolive India, eight have a “buy” rating, 12 have a “hold” rating and 11 have a “sell” rating.
DSP Mutual Fund says now is the time to buy rupee assets, citing competitive REER, strong services exports, remittances and attractive large cap valuations.
Indian rupee strengthens to two week high as Iran tensions ease, RBI Governor Sanjay Malhotra signals support, lower oil prices and Asian gains aid recovery.
Sources tell CNBC-TV18 that the promoter entity is the likely seller in the Premier Energies block deal, while multiple Foreign Institutional Investors, and Mutual Funds were buyers.
Kotak Institutional Equities, who is bearish on Divi’s Laboratories, said that the stock’s current valuations of 49 times its estimated price-to-earnings ratio for FY28, is already pricing in growth potential.